Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

METHOTREXATE

  • You have access
    Current Smoking Negatively Affects the Response to Methotrexate in Rheumatoid Arthritis in a Dose-responsive Way, Independently of Concomitant Prednisone Use
    Mary Safy-Khan, Maria J.H. de Hair, Paco M.J. Welsing, Jacob M. van Laar and Johannes W.G. Jacobs the Society for Rheumatology Research Utrecht (SRU)
    The Journal of Rheumatology October 1 2021, 48 (10) 1504-1507; DOI: https://doi.org/10.3899/jrheum.200213
  • You have access
    Safety of the Methotrexate–leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil)
    Markus Bredemeier, Roberto Ranza, Adriana M. Kakehasi, Aline Ranzolin, Inês G. da Silveira, Ana C.M. Ribeiro, David C. Titton, André L.S. Hayata, Hellen M.S. Carvalho, Bárbara S. Kahlow, Vander Fernandes, Paulo Louzada Jr., Manoel B. Bértolo, Ângela L.B.P. Duarte, José C. Macieira, José R.S. Miranda, Geraldo R.C. Pinheiro, Reginaldo B. Teodoro, Marcelo M. Pinheiro, Valéria Valim, Ivânio A. Pereira, Maria F.L.C. Sauma, Gláucio R.W. de Castro, Laurindo F. da Rocha Jr., Sâmia A.S. Studart, Morgana O. Gazzeta, Leticia G. da Silveira, Cristiano M. Lupo and Ieda M.M. Laurindo
    The Journal of Rheumatology October 1 2021, 48 (10) 1519-1527; DOI: https://doi.org/10.3899/jrheum.201248
  • Open Access
    Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs
    Arthur Kavanaugh, Rene R. Westhovens, Kevin L. Winthrop, Susan J. Lee, YingMeei Tan, Di An, Lei Ye, John S. Sundy, Robin Besuyen, Luc Meuleners, Mykola Stanislavchuk, Alberto J. Spindler, Maria Greenwald, Rieke Alten and Mark C. Genovese
    The Journal of Rheumatology August 1 2021, 48 (8) 1230-1238; DOI: https://doi.org/10.3899/jrheum.201183
  • You have access
    Benefits of Methotrexate Use on Cardiovascular Disease Risk Among Rheumatoid Arthritis Patients Initiating Biologic Disease-modifying Antirheumatic Drugs
    Fenglong Xie, Lang Chen, Huifeng Yun, Emily B. Levitan and Jeffrey R. Curtis
    The Journal of Rheumatology June 1 2021, 48 (6) 804-812; DOI: https://doi.org/10.3899/jrheum.191326
  • Open Access
    Descriptive Comparisons of the Effect of Apremilast and Methotrexate Monotherapy in Oligoarticular Psoriatic Arthritis: The Corrona Psoriatic Arthritis/Spondyloarthritis Registry Results
    Alexis Ogdie, Mei Liu, Meghan Glynn, Kelechi Emeanuru, Leslie R. Harrold, Sven Richter, Benoit Guerette and Philip J. Mease
    The Journal of Rheumatology May 1 2021, 48 (5) 693-697; DOI: https://doi.org/10.3899/jrheum.191209
  • Open Access
    Pegloticase in Combination With Methotrexate in Patients With Uncontrolled Gout: A Multicenter, Open-label Study (MIRROR)
    John K. Botson, John R.P. Tesser, Ralph Bennett, Howard M. Kenney, Paul M. Peloso, Katie Obermeyer, Brian LaMoreaux, Michael E. Weinblatt and Jeff Peterson
    The Journal of Rheumatology May 1 2021, 48 (5) 767-774; DOI: https://doi.org/10.3899/jrheum.200460
  • You have access
    Tumor Necrosis Factor Inhibitor Monotherapy Versus Combination Therapy for the Treatment of Psoriatic Arthritis: Combined Analysis of European Biologics Databases
    Matthew L. Thomas, Gavin Shaddick, Rachel Charlton, Charlotte Cavill, Richard Holland, Florenzo Iannone, Giovanni Lapadula, Simona Lopriore, Jakub Závada, Michal Uher, Karel Pavelka, Lenka Szczuková, Prodromos Sidiropoulos, Irini Flouri, Alexandros Drosos, Burkhard Möller, Michael J. Nissen, Rüdiger B. Müller, Almut Scherer, Neil McHugh and Alison Nightingale
    The Journal of Rheumatology January 1 2021, 48 (1) 48-57; DOI: https://doi.org/10.3899/jrheum.190815
  • You have access
    Initial Results from a Pilot Comparative Effectiveness Study of 3 Methotrexate-based Consensus Treatment Plans for Juvenile Localized Scleroderma
    Suzanne C. Li, Kathryn S. Torok, C. Egla Rabinovich, Fatma Dedeoglu, Mara L. Becker, Polly J. Ferguson, Sandy D. Hong, Maria F. Ibarra, Katie Stewart, Elena Pope, Gloria C. Higgins, Ronald M. Laxer, Thomas Mason II, Robert C. Fuhlbrigge and Tracy Andrews for the CARRA Registry Investigators
    The Journal of Rheumatology August 1 2020, 47 (8) 1242-1252; DOI: https://doi.org/10.3899/jrheum.190311
  • You have access
    Methotrexate in the Treatment of Idiopathic Granulomatous Mastitis
    Anna Postolova, Megan L. Troxell, Irene L. Wapnir and Mark C. Genovese
    The Journal of Rheumatology June 1 2020, 47 (6) 924-927; DOI: https://doi.org/10.3899/jrheum.181205
  • You have access
    Comparative Persistence of Methotrexate and Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Michael D. George, Joshua F. Baker and Alexis Ogdie
    The Journal of Rheumatology June 1 2020, 47 (6) 826-834; DOI: https://doi.org/10.3899/jrheum.190299

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire